Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ISRCTN13671354) titled 'A healthy volunteer imaging study to test two new tablet formulations designed to release in the duodenum (the first part of the small intestine)' on March 13.

Study Type: Observational

Study Design: Feasibility/Pilot study

Primary Sponsor: BDD Pharma Ltd

Condition: Duodenal drug delivery Other

Intervention: This is a non-CTIMP single centre, proof of concept, open-label, two arm, crossover study in up to 8 healthy male and female adult volunteers. This study will evaluate two novel drug delivery systems targeting duodenal drug release.

All participants will report to the Bio-Imaging Centre for all study ...